These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20492642)

  • 1. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.
    Kishimoto A; Todani A; Miura J; Kitagaki T; Hashimoto K
    Ann Gen Psychiatry; 2010 May; 9():23. PubMed ID: 20492642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2009 Dec; 8():26. PubMed ID: 20025739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurring depressive symptoms in the older patient with schizophrenia.
    Kasckow JW; Zisook S
    Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor.
    Stahl SM
    CNS Spectr; 2005 Apr; 10(4):319-23. PubMed ID: 15788959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder.
    Tadokoro S; Kanahara N; Kikuchi S; Hashimoto K; Masaomi I
    Ann Gen Psychiatry; 2011 Sep; 10():26. PubMed ID: 21962241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?
    Hashimoto K
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):470-4. PubMed ID: 19702566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine.
    Pallanti S; Sandner C
    Int J Psychiatry Clin Pract; 2007; 11(3):233-8. PubMed ID: 24941363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor.
    Matsushima Y; Terada K; Kamei C; Sugimoto Y
    Eur J Pharmacol; 2019 Jun; 853():129-135. PubMed ID: 30902656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Mar; 9():11. PubMed ID: 20205742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():17. PubMed ID: 20416096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jun; 9():28. PubMed ID: 20573265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Apr; 9():18. PubMed ID: 20416097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
    Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
    Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe depression: is there a best approach?
    Sonawalla SB; Fava M
    CNS Drugs; 2001; 15(10):765-76. PubMed ID: 11602003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM; Osser DN
    Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.
    Furuse T; Hashimoto K
    Ann Gen Psychiatry; 2010 Jan; 9():6. PubMed ID: 20148109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.